Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
47 /100
MEDIUM RISK
Score updated Aug 28, 2026

KPRX — Kiora Pharmaceuticals, Inc. Dilution Risk Tracker

Track KPRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KPRX — Get alerts when the score changes →

As of August 28, 2026, Kiora Pharmaceuticals, Inc. (KPRX) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. Kiora Pharmaceuticals, Inc. has a market capitalization of $11.88M, 4.42M shares outstanding, 17 institutional holders tracked. Stored dilution-related fields include 5.49M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰Cash Runway
📊 Float Risk
27
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 30%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 124% of shares outstanding
• Warrant risk score very high (90/100)
🔔 Track KPRX — Get forecast alerts →

Market Data

Market Cap$11.88M
Shares Outstanding4.42M
Float4.30M
Cash$16.84M
Debt$278.2K
Short InterestN/A

Institutional Holdings

QoQ: ↓ 59.0% shares (2026Q1 vs prior)
17 institutional holders · 359.0K shares
#1 ADAR1 Capital Management, LLC 167.9K shares
#2 CITADEL ADVISORS LLC 49.5K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 47.9K shares
+ 14 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.9K
Days to Cover1.0
% of Float0.1%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2023-12-31
8-K 8K EVENT 2026-04-07
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-04-02
Full SEC filing analysis available with free account

Recent News

No recent news

Factual KPRX Dilution Snapshot

Kiora Pharmaceuticals, Inc. (KPRX) has a DilutionScore of 47/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track KPRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KPRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for KPRX
KPRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.